Business & Industry
SK Telecom and SK Biopharmaceuticals Identify Lead Compounds for Cancer Treatment via AI
SK Telecom and SK Biopharmaceuticals have announced the successful identification of early lead compounds designed for the development of targeted therapies for intractable cancers. By leveraging AI Drug Discovery, the joint research team discovered two specific substances capable of...
Business & Industry
Senate Investigates Foreign Control and Ownership within the Pharmaceutical Sector
The Senate Special Committee on Aging is preparing to conduct a hearing titled "Behind The Label: Focusing On Foreign Ownership And Control In America's Drug Supply Chain." Scheduled for Wednesday, July 15, the session arrives as the industry faces...
Business & Industry
Germany to Double Mandatory Drug Rebates to 15.5 Percent
As European nations seek to stabilize their national health systems, the resulting regulatory changes are prompting a reassessment of market priority and supply chain reshoring. In a significant escalation of this trend, German lawmakers have finalized a sweeping health...
Business & Industry
AstraZeneca Secures Global Rights for Zegfrovy Lung Cancer Therapy
AstraZeneca has expanded its oncology pipeline through a $1.5 billion agreement with Dizal Pharma, securing the Zegfrovy global rights. This oral lung cancer therapy, also known as sunvozertinib, is an irreversible EGFR inhibitor. Currently, sunvozertinib is approved in China...
Business & Industry
FDA Proposes New Rule for Drug Manufacturing Registration
The modernization of regulatory frameworks is becoming essential to support the pharmaceutical industry’s transition toward advanced production models and to ensure the resilience of global supply chains. As innovative manufacturing technologies emerge, traditional oversight mechanisms must evolve to maintain...
News
How Modern Wellness Research Is Shaping Health Innovation
Science has always driven progress in health, but the pace of that progress has changed dramatically in recent years. Researchers are now looking beyond traditional medicine and exploring how the body's own biological systems can inform better approaches to...
News
The Starting Material Dilemma: De-Risking Early-Stage CAR-T and Immuno-Oncology Pipelines
The Operational Bottleneck in Advanced Therapeutics
The cell and gene therapy sector has transitioned from a proof of concept frontier into a highly competitive commercial market. While advanced gene editing tools like CRISPR and novel viral vectors dominate industry headlines,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
